Literature DB >> 15778351

IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity.

Marie-Christine Rouyez1, Marta Lestingi, Martine Charon, Serge Fichelson, Agnès Buzyn, Isabelle Dusanter-Fourt.   

Abstract

Class I MHC complexes (MHC(I)) are essential in mediating immune response. The transport of antigenic peptides (TAP) to MHC(I) and the stable expression of MHC(I) on the cell surface require the presence of a dedicated TAP. In this study we report that IFN-gamma and thrombopoietin (TPO) strongly increase TAP1 protein expression in megakaryocytes, followed by an enhanced expression of MHC(I) on the cell surface. This expression parallels the enhanced TAP1 promoter activity and TAP1 mRNA expression, which are independent of protein synthesis. We also show that this cytokine-dependent expression of TAP1 transcripts depends on STAT1 and IFN regulatory factor-2 (IRF-2), but not on IRF-1, and provide evidence that IRF-2 constitutively binds to the TAP1 gene promoter and enhances TAP1 promoter activity. We show that IRF-2 forms a complex with STAT1 and the cytokine-responsive region of the TAP1 promoter in any TPO or IFN-gamma target cells tested. Interaction of IRF-2 and STAT1 on the promoter depends on the DNA-binding domain of IRF-2. Overall, our data indicate that TPO and IFN-gamma activate the expression of TAP1 via a new mechanism that involves functional cooperation between STAT1 and IRF-2 on the TAP1 promoter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778351     DOI: 10.4049/jimmunol.174.7.3948

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.

Authors:  Juergen Bukur; Felix Herrmann; Diana Handke; Christian Recktenwald; Barbara Seliger
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

2.  Replacement of the C-terminal tetrapeptide (314 PAPV 317 to 314 SSSM 317) in interferon regulatory factor-2 alters its N-terminal DNA-binding activity.

Authors:  Krishna Prakash; Pramod C Rath
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

Review 3.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

Review 4.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

5.  Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.

Authors:  Michael S Leibowitz; Pedro A Andrade Filho; Soldano Ferrone; Robert L Ferris
Journal:  Cancer Immunol Immunother       Date:  2011-01-05       Impact factor: 6.968

6.  Dichotomy between factors inducing the immunosuppressive enzyme IL-4-induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes.

Authors:  Jeanine Marquet; Fanette Lasoudris; Céline Cousin; Marie-Line Puiffe; Nadine Martin-Garcia; Véronique Baud; Fanny Chereau; Jean-Pierre Farcet; Valérie Molinier-Frenkel; Flavia Castellano
Journal:  Eur J Immunol       Date:  2010-09       Impact factor: 5.532

7.  Mouse interferon regulatory factor-2: expression, purification and DNA binding activity.

Authors:  Krishna Prakash; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2011-05-11       Impact factor: 2.316

8.  Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Fang Lu; Kevin Tsai; Horng-Shen Chen; Priyankara Wikramasinghe; Ramana V Davuluri; Louise Showe; John Domsic; Ronen Marmorstein; Paul M Lieberman
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

9.  Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis.

Authors:  Jian Xu; Zhen Shao; Kimberly Glass; Daniel E Bauer; Luca Pinello; Ben Van Handel; Serena Hou; John A Stamatoyannopoulos; Hanna K A Mikkola; Guo-Cheng Yuan; Stuart H Orkin
Journal:  Dev Cell       Date:  2012-10-04       Impact factor: 12.270

10.  Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.

Authors:  Barry A Kriegsman; Pranitha Vangala; Benjamin J Chen; Paul Meraner; Abraham L Brass; Manuel Garber; Kenneth L Rock
Journal:  J Immunol       Date:  2019-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.